Save time and get answers to complex questions with AI chat
How does iron rich food intake impact lipitor's efficacy?When is xarelto's patent set to expire roughly?When genetic tenofovir alafenamide be available in us?When will tenofovir alafenide come off patent in canada?What's the recommended schedule for lurbinectedin side effect checks?
See the DrugPatentWatch profile for Osimertinib
The initial FDA approval for osimertinib (Tagrisso) was on November 13, 2015, for metastatic EGFR T790M mutation–positive NSCLC after progression on or after EGFR-TKI therapy. If you want a timeline of later approvals (e.g., first-line use, adjuvant use), I can summarize those dates as well.
Other Questions About Osimertinib :